Cabrini, Giulio http://orcid.org/0000-0003-2720-0742
Funding for this research was provided by:
Italian Cystic Fibrosis Foundation (FFC)
Article History
First Online: 26 November 2018
Compliance with Ethical Standards
:
: The author, Giulio Cabrini, declares no conflict of interest. GC is co-inventor, but not owner, of the US patent no. U.S.A. 9.183.206 B2 “Trimethylangelicin as CFTR corrector in bronchial epithelial cells.”
: This review was made possible by the support of different research projects with grants from the Telethon Foundation, CariVerona Foundation and Italian Cystic Fibrosis Research Foundation (FFC no. 17/2010, 1/2011, 5/2011, 1/2012, 1/2013, 8/2014, 17/2014, 9/2015, 1/2016, and 3/2016).